Subsequently, the BCR/ABL-independent activation of Stat5 increased P-glycoprotein (P-gp) activity in CM-mediated protection of CML stem cells (LSCs) from IM. This evidence concerns the gene STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive.